Clicks Group’s share price has fallen sharply in 2026. [1] It has reached levels not seen in a decade. [1] The decline has erased billions from the company’s market capitalization and prompted questions about whether its shares are undervalued or the market has permanently reassessed the business. [1]
Analysts cite a more complex and competitive pharmacy landscape as a key reason for the share price decline. [1] The sector’s growth outlook is seen as weaker than in previous years, when Clicks attracted foreign investors seeking high growth. [1]
In early September, a notice said JPMorgan Chase & Co. had reduced its beneficial interest in Clicks Group to 3.00%. [22]